(Total Views: 309)
Posted On: 09/20/2018 5:19:08 PM
Post# of 153897
NetworkNewsBreaks – CytoDyn Inc. (CYDY) Management Presenting at Two Upcoming Investment Conferences
CytoDyn (OTCQB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, this morning announced that company management is set to present at two upcoming conferences. First, the company will give a presentation at the Fourth Annual Robins Equity Research Roundup in Portland, Oregon on Tuesday, September 25, 2018 at 10:00 a.m. Pacific time. Next, CytoDyn will present at The MicroCap Conference at the Essex House in New York City on Monday, October 1, at 9:00 a.m. ET. A live webcast and replay of the company’s presentation at The MicroCap Conference will be accessible on the company’s website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
CytoDyn (OTCQB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, this morning announced that company management is set to present at two upcoming conferences. First, the company will give a presentation at the Fourth Annual Robins Equity Research Roundup in Portland, Oregon on Tuesday, September 25, 2018 at 10:00 a.m. Pacific time. Next, CytoDyn will present at The MicroCap Conference at the Essex House in New York City on Monday, October 1, at 9:00 a.m. ET. A live webcast and replay of the company’s presentation at The MicroCap Conference will be accessible on the company’s website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
